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Abstract In this review paper, we summarized the auto-
mated dementia identification algorithms in the literature from
a pattern classification perspective. Since most of those algo-
rithms consist of both feature extraction and classification, we
provide a survey on three categories of feature extraction
methods, including the voxel-, vertex- and ROI-based ones,
and four categories of classifiers, including the linear dis-
criminant analysis, Bayes classifiers, support vectormachines,
and artificial neural networks. We also compare the reported
performance of many recently published dementia identifica-
tion algorithms. Our comparison shows that many algorithms
can differentiate the Alzheimer’s disease (AD) from elderly
normal with a largely satisfying accuracy, whereas distin-
guishing the mild cognitive impairment from AD or elderly
normal still remains a major challenge.
Keywords Dementia  Computer-aided diagnosis 
Medical imaging  Image processing  Feature extraction 
Pattern classification
1 Introduction
Dementia is a chronic and progressive decline in cognitive
function due to the damage or disease in the brain beyond
what might be expected from normal aging [1]. There exist
many varieties of dementia, among which the Alzheimer’s
disease (AD) and frontotemporal dementia (FTD) are two
of the most common types [2–4]. AD is the most prevalent
dementia type, representing 60–80 % of the cases [5]. FTD
was once considered rare, but it is now thought to account
for up to 4 and 20 % of all dementia and memory disorders
in clinics [6] and may be as common as AD among people
younger than age 65 [7]. Other conditions that can also
cause dementia include Creutzfeldt–Jakob disease (CJD),
Huntington’s disease, Lewy body disease, Parkinson’s
disease, vascular dementia, and Wernicke–Korsakoff
syndrome.
Dementia is now a major global health and social threat.
It was estimated that 35.6 million people worldwide were
suffering from dementia in 2010 and the population was
predicted to be doubled every 20 years as the world pop-
ulation ages [8, 9]. Due to the rapid increase of dementia
cases, this disease has become an increasing death-factor
around the whole world [10]. It is shown that, from 2000 to
2010, the deathrate of heart disease, breast cancer, prostate
cancer, stroke, and HIV has dropped by 16, 2, 8, 23, and
42 %, respectively, whereas the deathrate of AD has
increased by an astonishing 68 % [11]. Even worse,
dementia generally presents a duration of more than
10 years after diagnosis [12], which may bring enormous
impact and financial burden on individuals, families, health
care systems, and societies as a whole [13–15].
The early symptoms of dementia include memory
problems, difficulties in word finding and thinking pro-
cesses, a lack of initiative, changes in personality or
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behavior, in day to day function at home, or at work, and in
taking care of oneself. Some symptoms are reversible,
whereas others are irreversible, depending upon the etiol-
ogy of the disease. If the dementia can be diagnosed at its
early stage, it is still possible to repair some reversible
damages and thus slow down the process of irreversible
damages, since evidences showed that the currently avail-
able medications for dementia, which can help people to
maintain daily function and quality of life as well as sta-
bilize cognitive decline, may be more beneficial if given
early in the disease process. For instance, about 10–30 %
of people with the mild cognitive impairment (MCI), which
is usually thought to be the incubation of AD in clinical
practice, develop to AD every year, whereas the conversion
rate of normal aging group is just 1–3 % [16]. According to
recent research, diagnosing MCI at its early stage and
taking corresponding measures to protect certain neuro-
logical functions of patients will help to slow down the
conversion from MCI to AD.
There exist some brief (5–15 min) tests that have rea-
sonable reliability and can be used in the office or other
settings to screen cognitive status for deficits which are
considered pathological. Examples of such tests include the
abbreviated mental test score (AMTS), mini-mental state
examination (MMSE), modified mini-mental state exami-
nation (3MS) [17], cognitive abilities screening instrument
(CASI) [18], and clock drawing test [19]. Although these
tests can help diagnosing different types of dementia, they
are generally recognized to be inadequate to classify the
types of dementia at an early stage. Some people perform
well on brief screening tests, but their memory and think-
ing impairments may be found with more comprehensive
testing. Moreover, some tests have been shown to have
educational, social, and cultural biases.
Medical imaging offers the ability to visualize degener-
ative histological changes, including the amyloid plaques,
hypo-metabolism, and atrophy introduced by neurological
disorders, which occur long before the neurodegenerative
disorder is clinically detectable [20]. Hence, the widespread
applications of medical imaging have led to a revolution in
the early diagnosis of dementia [21–24]. The commonly used
imaging modalities in dementia diagnosis include the mag-
netic resonance imaging (MRI), positron emission tomog-
raphy (PET), and single-photon emission computed
tomography (SPECT). Structural MRI uses a magnetic field
and radio waves to create detailed images of the organs and
tissues within human body and has been shown to be a sur-
rogate for early diagnosis of AD, particularly in subjects
clinically classified as amnestic MCI (aMCI) [25]. This
technique offers several advantages, including greater
availability, better soft tissue contrast, faster data acquisi-
tion, lower cost, and the possibility of automatically deriving
quantitative indices of regional atrophy [26]. Accordingly,
the validation of structure MRI as a marker of AD progres-
sion is the core project of the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI). Functional PET with various
radioactive tracers, e.g., 2-[18F]fluoro-2-deoxy-D-glucose
(FDG) and 18C-Pittsburgh Compound (11C-PiB), can detect
subtle changes in cerebral metabolism or amyloid deposition
prior to anatomical changes are evident or a symptomato-
logical diagnosis of probable dementia can be made with
structure imaging [27–30]. Functional SPECT is similar to
PET in its use of radioactive tracer material and detection of
gamma rays. SPECT scans have low spatial resolution than
PET scans, but are significantly less expensive. However, the
interpretation of PET and SPECT images remains a chal-
lenge because the changes can be subtle in the early course of
the disease and there can be some overlap with normal aging
and other dementia types [31].
Inmedical imaging based dementia diagnosis, the acquired
3D images are still analyzed almost entirely through visual
inspection on a slice-by-slice basis in search of familiar dis-
ease patterns. This requires a high degree of skill and con-
centration, and is time-consuming, expensive, and prone to
operator bias. Thus, there is a strong demand for computer-
aided automated dementia classification, which is expected to
provide a useful ‘‘second opinion’’ and enable doctors to
bypass the aforementioned issues. As a result, a great number
of computer-aided automated dementia identification
approaches have been proposed. The targets of those
approaches are in threefold: (1) differentiating dementia cases
fromnormal controls (NCs); (2) identifying different stages of
dementia, such as separating MCI from AD cases; and (3)
identifying different types of dementia, such as separatingAD
from FTD. There exist several publically available databases,
including the Early Lung Cancer Action Program (ELCAP)
[32], Open Access Series of Imaging Studies (OASIS) [33,
34], andAlzheimer’s diseaseNeuroimaging Initiative (ADNI)
[35]. These databases have been broadly used as the test bed in
many studies, and thus tremendously promoted the research
on automated dementia identification.
In this paper, we provide a survey of automated
dementia identification approaches in the literature from a
pattern classification perspective. Similar to other pattern
classification solutions, various dementia identification
approaches consist of two major steps: feature extraction
and classification. Hence, we review the feature extraction
methods and classifiers used in those approaches, respec-
tively. We also provide a comparison of the reported per-
formance of many available approaches.
2 Methods
Automated identification of dementia using medical
imaging with the aid of computers is essentially an image-
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based pattern recognition problem, which can be solved in
two successive steps: feature extraction and pattern clas-
sification. During the training stage, image features that can
characterize the patterns of various types or stages of
dementia are calculated based on the quantitative analysis
of medical images. Those features are usually selected and/
or combined to reduce their dimensionality before training
a classifier with the supervised learning techniques [36].
The trained classifier may be treated as a ‘‘black box,’’
which encapsulates the knowledge gleaned from the ima-
ges and is capable of producing the expected predictions
[37]. For each testing image, the features extracted,
selected, and combined in the same way are applied to the
trained classifier to generate a predicted class label that
indicates to which type or stage the dementia case belongs.
The diagram of a typical automated dementia identification
system is shown in Fig. 1.
Next, we will review the feature extraction methods and
classification methods used in the state of the art dementia
identification approaches, respectively.
2.1 Feature extraction methods
According to the types of features extracted from brain
images, feature extraction methods can be roughly grouped
into voxel-based, vertex-based, and ROI-based ones [38].
2.1.1 Voxel-based methods
Voxel-based methods can be traced back to the mid-1990s,
when Wright et al. [39] statistically analyzed the gray
matter and white matter voxel values for schizophrenia
diagnosis. Typically, voxel-based features consist of
statistics of voxel distributions on major brain tissues, such
as the gray matter, white matter, and cerebrospinal fluid
(CSF) [37, 40–43]. Magnin et al. [44] counted the voxel
value histogram in major anatomical regions, which could
be obtained by either image segmentation or registering a
brain atlas onto the image [44–46]. However, the
anatomical parcellation of brain is not a trivial task and
may not be adaptive to the pathology. Fan et al. [42] pro-
posed an adaptive parcellation approach, in which the
image space is divided into the most discriminative regions
[40, 41, 47–49]. The voxel-based morphometry (VBM)
method proposed by Ashburner et al. [50] allows investi-
gation of focal differences in brain anatomy using the
statistical parametric mapping (SPM), and hence greatly
facilitates the extraction of voxel-based features. Papa-
kostas et al. [51] successfully applied the VBM analysis to
feature extraction on MRI data. Recently, Liu et al. pro-
posed a simulation method to predict the longitudinal brain
morphological changes in neurodegenerative brains based
on VBM [52].
Fig. 1 Diagram of computer-aided identification of dementia
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Voxel-based features can be either directly used to con-
struct classifiers [43] or further processed to reduce its
dimensionality via feature selection, agglomeration, and
combination [38]. Vemuri et al. [37] used smoothing, voxel-
downsampling, feature selection, and combination to iden-
tify the features with the highest discriminatory power. Zhao
et al. [53] used the trace ratio linear discriminant analysis to
get the optimal feature projection, and thus reduced the
dimensionality of original features. Fan et al. [54] used a
high-dimensional template to wrap original data and
employed a watershed method to get the robust features.
2.1.2 Vertex-based methods
Clinical studies show that not only the volume of
anatomical regions matters in the early diagnose of
dementia, but also the vertex atrophy of the regions can
reflect the difference among AD, NC, and MCI [55–57].
Hence, another category of features is defined at the vertex-
level on the cortical surface. The cortical thickness repre-
sents a direct index of atrophy caused by dementia and can
be used in dementia diagnosis. Querbes et al. [56] devel-
oped a fast, robust, and fully automated method for cortical
thickness measurement. Lerch et al. [58] also proposed a
link between histopathologically confirmed changes and
cortical atrophy assessed through cortical thickness mea-
surement. Desikan et al. [55] parcellated the brain into
neocortical and non-neocortical ROIs by wrapping an
anatomical atlas and used the mean thickness and volume
of each ROI at the right and the left hemispheres as fea-
tures. In this method, the volumes are corrected using the
estimated total intracranial volume [38].
As an alternative to volumetric methods, cortical
thickness measurement has given promising results while
being less operator-dependent than the hippocampal vol-
ume measurements and is suitable for quantification and
localization [59]. The cognitive reserve is recognized as a
confounding factor in hiding early signs of dementia,
especially for subjects with a high education level who
would be more successful at coping with greater brain
damage [60–62]. The studies, which have investigated the
interaction between the cognitive reserve and neuroimag-
ing modes, showed that neuroimaging measurements may
reflect the underlying pathology better than neuropsy-
chometry since they are less affected by cognitive reserve
[61, 63–65]. However, clinical evaluations have shown the
limitations of vertex-based features in predicting the evo-
lution from the MCI stage to the dementia stage [66–69].
2.1.3 ROI-based methods
ROI-based methods define image features in one or more
major brain components, such as the cingulum, corpus
callosum, uncinate fasciculus, superior longitudinal fasci-
culus, and hippocampi. Pathological studies have shown
that neurodegeneration in AD begins in the medial tem-
poral lobe, successively affecting the entorhinal cortex,
hippocampus, and limbic system, and then extends toward
neocortical areas [70, 71]. There is a widespread agreement
that medial temporal atrophy, in particular hippocampal
atrophy, is a sensitive AD biomarker [72–74]. Hence,
hippocampi have been used as a marker of early AD in a
number of studies [38].
The widely used features include the volume or shape of
hippocampi or a weighted combination. Chupin et al. [75–
77] adopted the volume of the hippocampi as features, which
were normalized by the total intracranial volume (TIV)
summing up cortical parcellation maps of GM, WM, and
CSF inside a bounding box in a standard space. Westman
et al. [78] also used the hippocampal volume extracted on
MRI data as features and the orthogonal partial least squares
to latent structures (OPLS) analysis as the classifier to dif-
ferentiate AD and MCI from elderly normal subjects. When
it comes to the shape features, each segmented hippocampus
is described by a series of spherical harmonics (SPHARM),
whose coefficients were computed with the SPHARM-PDM
software developed by the University of North Carolina and
the National Alliance for Medical Imaging Computing [79].
Gerardin et al. [80] adopted two sets, one for each hip-
pocampus, of 3D SPHARM coefficients as features and used
an univariate feature selection method combined with a
bagging strategy to get the most discriminative features.
Atrophy in early stages of AD is not confined to the hip-
pocampus or the entorhinal cortex. Other areas are affected
in AD patients and MCI patients as well [4]. Therefore,
multi-ROI-based feature extraction has attracted a lot of
research attentions. Xia et al. [81] used the AAL cortical
parcellation map to separate 116 anatomical regions for
feature extraction. Liu et al. [82] proposed a multi-channel
pattern analysis approach to analyze the hypo-metabolism
patterns of AD andMCI on FDG-PET data and identified 21
brain regions as the most discriminative biomarkers.
In ROI-based methods, ROI segmentation is usually
performed before feature extraction. Since manual seg-
mentation is time-consuming and prone to operator-related
bias, automated segmentation of ROIs is badly needed.
Beside using probabilistic and anatomical priors for hip-
pocampus segmentation [75], Chupin et al. [76, 77] also
developed a fully automatic method called SACHA, which
uses the prior knowledge on the location of the hip-
pocampus and amygdala derived from a probabilistic atlas
and on the relative positions of these structures with respect
to the automatically identified landmarks [38]. The
SACHA algorithm segments both the hippocampus and
amygdala simultaneously based on competitive region-
growing between these two structures. It has shown that
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this approach is competitive with manual tracing for the
discrimination of patients with AD and MCI [75, 83].
2.2 Classification methods
With the features estimated on training cases, a classifier
can be trained and applied to predict the diagnosis of a
testing case, whose features are extracted in the same way.
The commonly used classifiers in dementia identification
include the linear discriminant analysis (LDA), Bayes
classifier, support vector machine (SVM), artificial neural
network (ANN), and other supervised ones [84, 85].
2.2.1 Linear discriminant analysis (LDA)
Since the number of brain voxels is huge, the features cal-
culated via voxel combination are of high dimension. LDA,
also known as the Fisher linear discriminant (FLD), is one of
the most popular dimensionality reduction methods [86].
LDA looks for low-dimensional linear combinations of
variables, which best explain the data, by maximizing the
between-class scatter matrix while minimizing the within-
class scatter matrix and form a linear discriminant function
resulting in least misjudgments [87–89]. Zhao et al. [53]
proposed an improved iterative trace ratio (iITR) algorithm
to solve the trace ratio linear discriminant analysis (TR-
LDA) problem for dementia diagnosis and achieved better
performance than the principal component analysis (PCA),
locality preserving projections (LPP), and maximummargin
criterion (MMC). Horn et al. [90] applied the image features
compressed by the partial least squares (PLS) to LDA for
differentiating AD from FTD and achieved an accuracy of
84 %, a sensitivity of 83 %, and a specificity of 86 % on
perfusion SPECT images.
LDA is closely related to analysis of variance and
regression analysis, which also attempt to express one
dependent variable as a linear combination of other fea-
tures or measurements [91]. LDA works well when the
features own the characteristic of clear classification, which
however is not possessed by most features extracted clin-
ical data.
2.2.2 Bayes classifiers
Bayes classifiers are a family of simple probabilistic clas-
sifiers based on Bayes’ theorem with strong (naive) inde-
pendence assumptions between the features. Seixas et al.
[10] proposed a Bayesian network decision model for
supporting diagnosis of AD, MCI, and NC, and achieved
better performance than several well-known classifiers,
including the na¨ive Bayes, logistic regression model,
multilayer perceptron ANN, decision table, decision stump
optimized by the Adaboost algorithm and J48 decision tree.
Liu et al. [92] proposed the multifold Bayesian Kernel-
ization method, which can differentiate AD from NC with
a high accuracy, but achieved poor results in diagnosing
MCI-converter (MCIc) and MCI-non-converter (MCInc).
Plant et al. [93] combined the feature selection with clas-
sification using a Bayes classifier for the discrimination
between AD and NC on MRI data and reported an accuracy
of up to 92 %. Lopez et al. [94] applied the multivariate
methods, such as PCA and LDA, to feature extraction, and
then employed the Bayesian framework for automated
diagnosis of AD and NC using PET and SPECT.
2.2.3 Support vector machine (SVM)
A SVM constructs a hyperplane or a set of hyperplanes in a
high- or infinite-dimensional space, which can be used for
classification, regression, or other tasks [95]. Since the
constructed hyperplane has the largest distance to the
nearest training data points of any class, SVMs in general
have lower generalization error than other classifiers, and
hence have been commonly used to solve pattern classifi-
cation problems which have limited training samples [38,
96–98]. Klo¨ppel et al. [43] first used the SVM-based cri-
teria to select the most discriminative features, and then
applied the SVM-based classifier to diagnose healthy
controls and schizophrenia patients using MRI brain ima-
ges. Vemuri et al. [37] also used SVM as both feature
selection criteria and a classifier, and achieved a sensitivity
of 86 % and a specificity of 92 % in AD diagnosis on MRI
data. Schmitter et al. [99] used SVM to verify that two
distinct VBM algorithms, i.e., the FreeSurfer and an in-
house algorithm MorphoBox, can achieve comparable
results to the conventional whole-brain VBM techniques.
Hackmack et al. [100] firstly used the dual-tree wavelet
transform to extract features, and then used a linear SVM
to discriminate multiple sclerosis from NC. Dukart et al.
[101] used the meta-analysis- based-SVM to diagnose AD
and NC on both MRI and PET data and achieved an
accuracy of 90.0 %, a sensitivity of 91.8 % and a speci-
ficity of 87.8 %. Ortiz et al. [102] used the SVM classifier
to verify the performance of three different feature
extraction methods, including PCA, learning vector quan-
tization (LVQ), and voxels as features (VAF) and
demonstrated that LVQ features could generate the best
result. Nir et al. [103] used the fiber-tract modeling method
to extract image features and applied SVM to differenti-
ating AD from NC and achieved an accuracy of 86.2 %, a
sensitivity of 88.0 %, and a specificity of 89.2 %.
2.2.4 Artificial neural network (ANN)
ANNs are a family of models inspired by biological
neural networks and are used to estimate or
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approximate functions that depend on a large number
of inputs and are generally unknown. They have been used
to solve a wide variety of tasks that are hard to solve using
ordinary rule-based programming. Deng et al. [104] showed
that using ANN can get higher sensitivity and accuracy than
traditional discriminant function analysis [105] in dementia
classification using MRI. Huang et al. [105] combined the
VBM technique and ANN to differentiate AD from NC and
achieved 100 % accuracy. Garcı´a-Pe´rez et al. [106]
employed the artificial neural network technology to build an
automaton to assist neurologists during the differential
diagnosis of AD andVD. The recent studies also suggest that
deep learning, which is usually based on a hierarchical ANN,
is effective in capturing high-level variations of brain images
and improves the dementia classification [107–109].
Generally, ANN can be viewed as a ‘black box’ for the
best discriminant analysis. Due to its parallel nature, ANN
can easily take the advantage of hardware development and
is typically suitable for solving classification problems with
massive training data. However, tuning the parameters
involved in ANN is often time-consuming, which has ham-
pered the application of ANNs to dementia identification.
So far we have reviewed the application of four classical
pattern classification methods to automated dementia
identification. It is worth noting that dementia identifica-
tion is essentially a supervised classification problem, and
hence, the advances in supervised machine learning and
pattern classification can find immediate application on this
topic.
3 Performance comparison
There are several comparative studies in the literature.
Horn et al. [90] applied a set of 116 descriptors, which
correspond to the average activity in ROIs calculated from
the images of 82 AD and 91 FTD patients, to a number of
linear and nonlinear classifiers, including the logistic
regression, LDA, SVM, KNN, multilayer perceptron, and
kernel logistic PLS. They compared the performance of
those classifiers in differentiating AD from FTD and con-
cluded that the PLS ? KNN is the best method since it
achieves the highest accuracy with leave-one-out cross-
validation. Cuingnet et al. [38] evaluated the performance
of ten approaches in automatically discriminating between
patients with AD, MCI, and elderly controls using the T1-
weighted MRI data acquired on 509 subjects from the
ADNI database. In those approaches, the classifier is SVM
and the involved feature extraction methods can be
grouped into three categories. The first category is based on
segmented tissue probability maps, including directly using
the voxels of the tissue probability maps as features [43],
using the STAND score [37], grouping the voxels into
anatomical regions as features using a labeled atlas [44],
and aggregating voxel values in homogeneously discrimi-
native regions to form features [42]. The second category is
based on the cortical thickness, including direct, atlas-
based, and ROI-based methods. The third category is based
on hippocampi, including the volume and shape of left and
right hippocampus. They concluded that, for AD versus
CN, whole-brain methods achieved high accuracies (up to
81 % sensitivity and 95 % specificity); for the detection of
MCIc, the sensitivity was substantially lower; and for the
prediction of conversion, no classifier obtained signifi-
cantly better results than chance.
Next, we compare the performance of the automated
dementia identification methods published in recent years
in Table 1. It reveals that, when differentiating AD from
NC, many methods can achieve an accuracy of[90 % and
even 100 % on smaller datasets, whereas when separating
MCI from AD or NC, the performance of those methods is
much lower.
4 Perspective
Due to the advances inmedical imaging, it is now possible to
sequentially capture two separate yet complementary
information of a patient study in a single scan, i.e., PET/CT
[110]. Furthermore, it is predicted that the next-generation
molecular imaging modalities will continuously advance in
multi-modality paradigm, such as the recent development of
PET/MRI and SPCET/CT [111]. Multimodal neuroimaging
has several distinct advantages over single modality neu-
roimaging, including improving both spatial and temporal
resolution, finding the anatomical basis for functional con-
nectivity, targeting disease biomarkers with high specificity
and sensitivity, along with many new opportunities to
improve brain research [109]. Recently, Gray et al. [112]
proposed a multi-modality classification framework, in
which manifolds are constructed based on pairwise simi-
larity measures derived from random forest classifiers, and
achieved classification accuracies of 89 % between AD and
NC, and 75 % between MCI and NC. Liu et al. [113] sum-
marized the recent advances in multimodal neuroimaging
technologies, along with their applications to the neuropsy-
chiatric disorders. We believe that the application of multi-
modality neuroimaging will substantially improve the per-
formance of automated dementia identification.
5 Conclusion
In this paper, we provide a brief review of automated
dementia identification algorithms, which from a pattern
classification perspective can be divided into two stages:
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feature extraction and classification. We summarize the
voxel-based, vertex-based, and ROI-based feature extrac-
tion methods and LDA-based, Bayesian, SVM-based, and
ANN-based pattern classification methods used in various
dementia identification algorithms. We also compare the
performance of some of those algorithms. The comparison
shows that satisfying diagnosis of AD and NC can be
achieved by many algorithms; whereas differentiating MCI
from AD or NC still remains a major challenge. Therefore,
more research effort should be devoted to discovering the
patterns embedded in brain images of MCI patients. We
expect novel solutions could be proposed to address this
issue.
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